• 1987

Company Description

Karo Bio is a pharmaceutical company focused on the research and development of innovative drugs for unmet medical needs.

Karo Bio is a pharmaceutical company focused on the research and development of innovative drugs for unmet medical needs. The foundation for the company’s activities is its unique knowledge of nuclear receptors as target proteins for the development of novel pharmaceuticals. Karo Bio is active in preclinical development in the areas of neuropsychiatry, inflammation, autoimmune diseases and cancer. Important processes in the company are research, drug discovery, and preclinical development. In addition to these processes, Karo Bio also has medical and regulatory expertise. Karo Bio has the capacity to process selected compounds for niche indications through the entire development process, while compounds addressing large patient groups require development collaborations or outlicensing at some stage of the development process. Karo Bio has three development projects and a number of strategic collaborations with international pharmaceutical companies.